Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Ridgeline Therapeutics: NNMT inhibitor drugs licensed from UTMB research
Dealroom.co1 min read
Ridgeline Therapeutics: NNMT inhibitor drugs licensed from UTMB research Dealroom
Read the full article at Dealroom.coRelated coverage
AI Products
XtalPi Holdings Limited: XtalPi Holdings Announces 2026 Interim Results
finanznachrichten.de · Aug 19, 2026
AI & Society
How to build a cancer vaccine, and whether they will work this time
LessWrong · Jun 8, 2026
AI Research
Foundries vs Navigators: Lowering the Cost of Science
Latent Space · Sep 24, 2026
Psychedelic medicine is approaching a turning point. The U.S. needs the right infrastructure to be ready
Fortune · Oct 12, 2026